Search hospitals > Illinois > Elmhurst
Elmhurst Memorial Hospital
Claim this profileElmhurst, Illinois 60126
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Breast cancer
Conducts research for Stomach Cancer
91 reported clinical trials
14 medical researchers
Summary
Elmhurst Memorial Hospital is a medical facility located in Elmhurst, Illinois. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Breast cancer, Stomach Cancer and other specialties. Elmhurst Memorial Hospital is involved with conducting 91 clinical trials across 146 conditions. There are 14 research doctors associated with this hospital, such as Brian C. Myre, Samir D. Undevia, Maria I. Quejada, and Sania S. Raza.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
PR positive
Top PIs
Brian C. MyreElmhurst Memorial Hospital5 years of reported clinical research
Studies Skin Cancer
Studies Renal Cell Carcinoma
7 reported clinical trials
28 drugs studied
Samir D. UndeviaElmhurst Memorial Hospital9 years of reported clinical research
Studies Skin Cancer
Studies Melanoma
5 reported clinical trials
26 drugs studied
Maria I. QuejadaElmhurst Memorial Hospital10 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
4 reported clinical trials
7 drugs studied
Sania S. RazaElmhurst Memorial Hospital5 years of reported clinical research
Studies Colorectal Cancer
Studies Stomach Cancer
4 reported clinical trials
17 drugs studied
Clinical Trials running at Elmhurst Memorial Hospital
Skin Cancer
Ovarian Cancer
Breast Cancer
Lung Cancer
Prostate Cancer
Bladder Cancer
Cutaneous Melanoma
Kidney Cancer
Pancreatic Carcinoma
Cancer
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy With or Without Surgery
for Kidney Cancer
This phase III trial compares the effect of adding surgery to a standard of care immunotherapy-based drug combination versus a standard of care immunotherapy-based drug combination alone in treating patients with kidney cancer that has spread to other places in the body (metastatic). Immunotherapy with monoclonal antibodies, such as nivolumab, ipilimumab, pembrolizumab, and avelumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Axitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Surgery to remove the kidney, called a nephrectomy, is also considered standard of care; however, doctors who treat kidney cancer do not agree on its benefits. It is not yet known if the addition of surgery to an immunotherapy-based drug combination works better than an immunotherapy-based drug combination alone in treating patients with kidney cancer.
Recruiting2 awards Phase 316 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Elmhurst Memorial Hospital?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.